News & Events
Press Releases and Publications
2024
Procyrion Closes $57.7 Million in Series E Financing
Houston innovator plays the long game of life science innovation with optimized capital efficiency
2023
Pulmotect Receives First Tranche of $8.9 Million from The State of Texas
Pulmotect Awarded $8.9 Million from The State of Texas
2022
Brevitest Publication: Assessing Immunity by Quantitative Measurement of SARS-CoV-2 IgG Antibodies in Fingerstick Samples
Fannin Innovation Studio Accepted Into NIDA’s Medications Discovery Program
2021
Pulmotect Reports Positive Topline Results from Randomized, Placebo Controlled Phase-2 Trial of PUL-042 against COVID-19
Fannin Innovation Studio Awarded $2,000,000 NIH Grant for Development of a Novel Antivenom Therapeutic Based on Next-Generation Aptamers
Innovation studio aims to put Houston on the map for life science startup development
Pulmotect receives Department of Defense funding for Phase-2 trials of PUL-042 against COVID-19
Raptamer Discovery Group Awarded SBA Tibbetts Award
2020
Allterum Therapeutics completes Series Seed
Allterum Granted Two Designations by the FDA
Salivary IgA antibodies against SARS-CoV-2
Brevitest becomes first remote resident of LaunchPort™
Pulmotect receives FDA approval to commence two Phase-2 trials targeting COVID-19
Allterum closes $2.9 million CPRIT award and initiates drug manufacturing scale-up with FujiFilm Diosynth
Pulmotect Shows Promising Pre-Clinical Efficacy in Preventing Lethal Coronavirus Infection
2019
Fannin Attracts Experienced Financier/MD to Houston
Chorioanchor Awarded SBIR Grant from NIH
Brevitest Awarded SBIR Phase II Grant from NIDA
Dr. Colin Broom Joins Pulmotect Inc. as Chief Executive Officer
Think Houston, think India, think biomedical innovation [Opinion]
Pulmotect Announces Election of Dr. Kumar Srinivasan
Procyrion Names Av Edidin, Ph.D., as Senior Vice President of Development and Manufacturing
Fannin Awarded NIH Grant For Atrapos
Houston Chronicle-Procyrion passes key FDA milestone
Ten New Fellows Join Fannin’s Fellowship Program
Procyrion Receives FDA Breakthrough
Procyrion Raises $30 Million Series D to Support Clinical Trials of its Aortix™ Percutaneous Blood Pump for Treating Heart Failure Patients
Fannin Closes $5.25 Million Fundraising Round
Procyrion Closes Series ‘D’
2018
Elizabeth Hoff Joins Fannin – HBJ
Fannin Fellows Promoted
Elizabeth Hoff Joins Fannin
Procyrion Names Av Edidin, Ph.D., as Senior Vice President of Development and Manufacturing
Procyrion Receives FDA Breakthrough Device Designation for Aortix™ System
Procyrion Selects Former Abbott/St. Jude Medical Group President Dr. Eric S. Fain as CEO
Medical Device Company Procyrion, Inc. Hires Three to Support Growth; Continues to Build Team
Procyrion, Inc. Wins Best Overall Medical Device Product in 2018 MedTech Breakthrough Awards
Procyrion, Inc. Announces ISO 13485:2016 Certification
Procyrion Featured in The Houston Chronicle: Health-care companies got most venture funds in Houston in Q1
Pulmotect Closes Series ‘B’
Procyrion Names Elisabeth Neely Senior Vice President of Clinical and Regulatory Affairs, Formerly with Abbott
ChorioAnchor Receives NIH Grant
Acelerox Receives CPRIT Award
Procyrion Raises $16 Million Series C for Clinical Trials of its Breakthrough Aortix™ Heart Pump
Procyrion Honored As An Innovator Reshaping Texas
Fannin Receives 3rd SBA Award
2017
Fannin Hires New Fellows
Acelerox Receives NIH Award for Alzheimer’s
Stent-X Receives NIH Award
Fannin’s Atrapos Wins NIH Award for Eczema
Fannin’s rHDL Wins NIH Award for Cancer Research
Fannin’s Exotect Wins NIH Award for Lung Disease Research
Fannin Wins SBA Tibbetts Award
2016
Melissa Singh Named Principal
GuidaBot Wins NSF Grant
Fannin Wins SBA Award
Fannin Renovates and Expands Offices
BreviTest Wins Award for Cannabis Testing
Pulmotect Completes Second Clinical Trial
Fannin Hires New Fellows